Ron is giving an Oral Presentation at the AACR Annual Meeting on Apr 2, 2019.
Patient-derived organoids and xenografts identify neratinib plus HER2 antibody drug conjugate as a synergistic drug combination for HER2 mutated, nonamplified breast cancer.
Presentation time: 4:40pm on April 2, 2019
Session: MS.TB01.01 – Nonclinical Models of Cancer
Location: Room A311 – Georgia World Convention Center, Atlanta.
Ron gave an interview to local NBC news on June 18, 2018 to discuss results from a breast cancer trial, TAILORx that uses the 27-gene qtPCR test, Oncotype Dx to determine which patients will benefit from chemotherapy after surgery. Click here to view it.
CONGRATULATIONS to Dr. Sarpong!
Runjun Kumar successfully defended his PhD thesis on July 14, 2016. He is doing residency and fellowship in Human Genetics at Baylor College of Medicine, Houston.
CONGRATULATIONS to Dr. Kumar!
Ron has given a Podcast Interview to the Journal of Biological Chemistry (JBC).
Click here to view or listen to it.